Next-Gen Therapies for Metabolic and Endocrine Disorders Beyond Conventional Approaches

Addressing the growing need for innovative and effective treatments for metabolic and endocrine disorders, which affect millions of individuals worldwide, this volume explore the cutting-edge developments in the field, offering a comprehensive overview of emerging therapies that promise to revolutionize patient care. From gene therapy and personalized medicine to advancements in pharmacology and biotechnology, this new book encapsulates the future of treatment modalities that promise to revolutionize patient care. Providing a comprehensive review of emerging therapies, supported by robust scientific evidence and clinical trials, the book delves into the mechanisms of action, potential benefits, and practical applications of these next-gen therapies for metabolic and endocrine disorders, offering healthcare professionals a valuable resource to enhance their practice.

Taking a forward-thinking approach, the authors not only discuss the current state of next-gen therapies but also envision future directions and innovations that could further transform the landscape of metabolic and endocrine disorder management. Chapters cover novel therapeutic approaches to metabolic syndromes, such as single-cell transcriptomics, therapeutic approaches to newer classes of drugs and treatments for type 2 diabetes mellitus, the use of artificial intelligence and the internet of things in diagnosis and management of diabetes mellitus, to name a few. The book offers state-of-the-art therapeutic approaches for such health issues as thyroid disorders, type 2 diabetes mellitus, diabetic gastroparesis, high cholesterol, phenylketonuria, cerebrovascular diseases, chronic renal failure, adrenal metabolic disorders, Gaucher disease, Parkinson disease, etc.

An essential reference, guiding healthcare professionals towards more effective, personalized, and innovative treatments, this volume will inspire ongoing research and clinical advancements, ultimately leading to improved outcomes and quality of life for patients worldwide.